Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer
Condition: Neoplasms Interventions: Drug: GSK3901961; Drug: Cyclophosphamide; Drug: Fludarabine Sponsor: GlaxoSmithKline Terminated
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Liposarcoma | Lung Cancer | Non-Small Cell Lung Cancer | Research | Sarcomas | Study | Synovial Sarcoma